BioCentury | Jan 27, 2003
Company News

MetaProbe Inc., University of Michigan deal

...the technologies will focus on improving detection, staging and treatment of hepatobiliary and vascular disorders. MetaProbe...
BioCentury | Sep 9, 2002
Company News

MetaProbe Inc. management update

MetaProbe Inc. , San Diego, Calif. Business: Diagnostics/Imaging Hired: William Dow as VP of R&D, formerly VP of chemical R&D at Pharmacyclics Inc. WIR Staff...
BioCentury | May 15, 2000
Company News

MassTrace Inc. deal

...A Japanese pharmaceutical company will use MassTrace's metaprobe biomarker technology in a pharmacogenomic test for the...
BioCentury | Apr 19, 1999
Company News

MassTrace Inc., Transcend deal

MassTrace acquired intellectual property from TSND and Cornell University (New York, N.Y.), including 82 issued patents and 34 patent applications, of which 12 are issued patents covering compositions of matter that MassTrace intends to develop...
Items per page:
1 - 4 of 4
BioCentury | Jan 27, 2003
Company News

MetaProbe Inc., University of Michigan deal

...the technologies will focus on improving detection, staging and treatment of hepatobiliary and vascular disorders. MetaProbe...
BioCentury | Sep 9, 2002
Company News

MetaProbe Inc. management update

MetaProbe Inc. , San Diego, Calif. Business: Diagnostics/Imaging Hired: William Dow as VP of R&D, formerly VP of chemical R&D at Pharmacyclics Inc. WIR Staff...
BioCentury | May 15, 2000
Company News

MassTrace Inc. deal

...A Japanese pharmaceutical company will use MassTrace's metaprobe biomarker technology in a pharmacogenomic test for the...
BioCentury | Apr 19, 1999
Company News

MassTrace Inc., Transcend deal

MassTrace acquired intellectual property from TSND and Cornell University (New York, N.Y.), including 82 issued patents and 34 patent applications, of which 12 are issued patents covering compositions of matter that MassTrace intends to develop...
Items per page:
1 - 4 of 4